litlas
Log inCreate account

Richard Görlick

Active 1996–2025

Also published as
Richard Gorlick
141
Papers
23,299
Citations
88
h-index
139
i10-index

Citations

Citations per year for Richard Görlick1986: 1 citations1992: 1 citations1993: 1 citations1994: 2 citations1996: 2 citations1997: 1 citations1998: 10 citations1999: 25 citations2000: 8 citations2001: 22 citations2002: 38 citations2003: 58 citations2004: 80 citations2005: 103 citations2006: 106 citations2007: 103 citations2008: 134 citations2009: 176 citations2010: 178 citations2011: 157 citations2012: 157 citations2013: 162 citations2014: 138 citations2015: 181 citations2016: 167 citations2017: 161 citations2018: 140 citations2019: 736 citations2020: 867 citations2021: 840 citations2022: 702 citations2023: 559 citations2024: 891 citations2025: 436 citations2026: 7 citations1987–1991: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,843 citing papers, 26.5% of this breakdownChina: 1,562 citing papers, 22.4% of this breakdownUnited Kingdom: 349 citing papers, 5% of this breakdownGermany: 311 citing papers, 4.5% of this breakdownItaly: 304 citing papers, 4.4% of this breakdownFrance: 249 citing papers, 3.6% of this breakdownCanada: 210 citing papers, 3% of this breakdownAustralia: 202 citing papers, 2.9% of this breakdownJapan: 169 citing papers, 2.4% of this breakdownNetherlands: 166 citing papers, 2.4% of this breakdownSpain: 151 citing papers, 2.2% of this breakdownSwitzerland: 112 citing papers, 1.6% of this breakdown
0%26.5%Other 19.1%

Institutions

Fields

  • Medicine54%
  • Biochemistry, Genetics and Molecular Biology34.9%
  • Immunology and Microbiology3.8%
  • Engineering3.1%
  • Materials Science1%
  • Computer Science0.7%
  • Other2.5%

Topics

  • Sarcoma Diagnosis and Treatment9.1%
  • Cancer-related molecular mechanisms research2.9%
  • MicroRNA in disease regulation2.5%
  • Neuroblastoma Research and Treatments2.5%
  • CAR-T cell therapy research2.2%
  • Bone Tumor Diagnosis and Treatments2.1%
  • Other78.7%

Coauthors

All papers

Open in search
  1. Advancing therapy for osteosarcoma

    Authors: Jonathan Gill, Richard Görlick - Nature Reviews Clinical Oncology 2021 cited by 874

  2. Osteosarcoma

    Authors: Hannah C. Beird, Stefan Bielack, Adrienne M. Flanagan, Jonathan Gill, Dominique Heymann, Katherine A. Janeway, J. Andrew Livingston, Ryan D. Roberts, Sandra J. Strauss, Richard Görlick - Nature Reviews Disease Primers 2022 cited by 595

  3. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

    Authors: Michael S. Isakoff, Stefan Bielack, Paul S. Meltzer, Richard Görlick - Journal of Clinical Oncology 2015 cited by 1,604

  4. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Authors: Sigbjørn Smeland, Stefan Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn, Mark Krailo, Richard Görlick, Katherine A. Janeway, Fiona C. Ingleby, Jakob Anninga, Imre Antal, Carola Arndt, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Michael Capra, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Godehard Friedel, Mark C. Gebhardt, Hans Gelderblom, Robert E. Goldsby, Holcombe E. Grier, R. J. Grimer, Douglas S. Hawkins, Stefanie Hecker‐Nolting, Kirsten Sundby Hall, Michael S. Isakoff, Gordana Jovic, Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina - European Journal of Cancer 2019 cited by 726

  5. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Authors: Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, Mark L. Bernstein, Gordana Jovic, Mark Krailo, Jane Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan, Bénédicte Brichard, Ken Brown, Trude Butterfaß‐Bahloul, Gabriele Calaminus, Heike E. Daldrup‐Link, Mikael Eriksson, Mark C. Gebhardt, Hans Gelderblom, Joachim Gerß, Robert E. Goldsby, Allen M. Goorin, Richard Görlick, Holcombe E. Grier, Juliet Hale, Kirsten Sundby Hall, Jendrik Hardes, Douglas S. Hawkins, K. Helmke, Pancras C.W. Hogendoorn, Michael S. Isakoff, Katherine A. Janeway, Heribert Jürgens, Leo Kager, Thomas Kühne, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Paul A. Meyers, Hubert Mottl, Michaela Nathrath, Zsuzsanna Pápai, R. Lor Randall, Peter Reichardt, Marleen Renard, Akmal Safwat, Cindy L. Schwartz, Michaël C.G. Stevens, Sandra J. Strauss, Lisa A. Teot, Mathias Werner, Matthew R. Sydes, Jeremy Whelan - The Lancet Oncology 2016 cited by 541

  6. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Authors: Stefan Bielack, Sigbjørn Smeland, Jeremy Whelan, Neyssa Marina, Gordana Jovic, Jane Hook, Mark Krailo, Mark C. Gebhardt, Zsuzsanna Pápai, James S. Meyer, Helen Nadel, R. Lor Randall, Claudia Deffenbaugh, Rajaram Nagarajan, Bernadette Brennan, G. Douglas Letson, Lisa A. Teot, Allen M. Goorin, Daniel Baumhoer, Leo Kager, Mathias Werner, Ching C. Lau, Kirsten Sundby Hall, Hans Gelderblom, Paul A. Meyers, Richard Görlick, Rein hard Windhager, K. Helmke, Mikael Eriksson, Peter M. Hoogerbrugge, Paula J. Schomberg, Per‐Ulf Tunn, Thomas Kühne, Heribert Jürgens, Henk van den Berg, Tom Böhling, Susan Picton, Marleen Renard, Peter Reichardt, Joachim Gerß, Trude Butterfaß‐Bahloul, Carol D. Morris, Pancras C.W. Hogendoorn, Beatrice Seddon, Gabriele Calaminus, Maria Michelagnoli, Catharina Dhooge, Matthew R. Sydes, Mark L. Bernstein - Journal of Clinical Oncology 2015 cited by 421

  7. Current and future therapeutic approaches for osteosarcoma

    Authors: Douglas J. Harrison, David S. Geller, Jonathan Gill, Valerae O. Lewis, Richard Görlick - Expert Review of Anticancer Therapy 2017 cited by 715

  8. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma

    Authors: Lisa Mirabello, Bin Zhu, Roelof Koster, Eric Karlins, Michael Dean, Meredith Yeager, Matthew Gianferante, Logan G. Spector, Lindsay M. Morton, Danielle M. Karyadi, Leslie L. Robison, Gregory T. Armstrong, Smita Bhatia, Lei Song, Nathan Pankratz, Maísa Pinheiro, Julie M. Gastier‐Foster, Richard Görlick, Sílvia Regina Caminada de Toledo, Antônio Sérgio Petrilli, Ana Patiño‐García, Fernando Lecanda, Miriam Gutiérrez-Jimeno, Massimo Serra, Claudia Maria Hattinger, Piero Picci, Katia Scotlandi, Adrienne M. Flanagan, Roberto Tirabosco, Maria Fernanda Amary, Nilgün Kurucu, İlhan İnci, Mandy L. Ballinger, David M. Thomas, Donald A. Barkauskas, Gerardo Mejia-Baltodano, Patricia Valverde, Belynda Hicks, Bin Zhu, Mingyi Wang, Amy Hutchinson, Margaret A. Tucker, Joshua N. Sampson, Maria Teresa Landi, Neal D. Freedman, Susan M. Gapstur, Brian S. Carter, Robert N. Hoover, Stephen J. Chanock, Sharon A. Savage - JAMA Oncology 2020 cited by 252

  9. The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

    Authors: Nathan M. Kendsersky, Jarrett M. Lindsay, E. Anders Kolb, Malcolm A. Smith, Beverly A. Teicher, Stephen W. Erickson, Eric J. Earley, Yaël P. Mossé, Daniel Martínez, Jennifer Pogoriler, Kateryna Krytska, Khushbu Patel, David Groff, Matthew Tsang, Samson Ghilu, Yifei Wang, Steven Seaman, Yang Feng, Brad St. Croix, Richard Görlick, Raushan T. Kurmasheva, Peter J. Houghton, John M. Maris - Clinical Cancer Research 2021 cited by 122

  10. Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

    Authors: Joanne Lagmay, Mark Krailo, Ha Dang, AeRang Kim, Douglas S. Hawkins, Orren Beaty, Brigitte C. Widemann, Theodore Zwerdling, Lisa Bomgaars, Anne‐Marie Langevin, Holcombe E. Grier, Brenda J. Weigel, Susan M. Blaney, Richard Görlick, Katherine A. Janeway - Journal of Clinical Oncology 2016 cited by 193

  11. IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines

    Authors: Zhiliang Jia, Dristhi Ragoonanan, Kris M. Mahadeo, Jonathan Gill, Richard Görlick, Elizabeth Shpal, Shulin Li - Frontiers in Immunology 2022 cited by 89

  12. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

    Authors: David S. Shulman, Kelly Klega, Alma Imamović, Andrea Clapp, Anwesha Nag, Aaron R. Thorner, Eliezer M. Van Allen, Gavin Ha, Stephen L. Lessnick, Richard Görlick, Katherine A. Janeway, Patrick J. Leavey, Leo Mascarenhas, Wendy B. London, Kieuhoa T. Vo, Kimberly Stegmaier, David Hall, Mark Krailo, Donald A. Barkauskas, Steven G. DuBois, Brian D. Crompton - British Journal of Cancer 2018 cited by 137

  13. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

    Authors: Jo Lynne Rokita, Komal S. Rathi, Maria Cardenas, Kristen Upton, Joy C. Jayaseelan, Katherine L. Cross, Jacob Pfeil, Laura E. Egolf, Gregory P. Way, Alvin Farrel, Nathan M. Kendsersky, Khushbu Patel, Krutika S. Gaonkar, Apexa Modi, Esther R. Berko, Gonzalo López, Zalman Vaksman, Chelsea Mayoh, Jonas Nance, Kristyn McCoy, Michelle Haber, Kathryn Evans, Hannah McCalmont, Katerina Bendak, Julia Böhm, Glenn M. Marshall, Vanessa Tyrrell, Karthik Kalletla, Frank Braun, Lin Qi, Yunchen Du, Huiyuan Zhang, Holly Lindsay, Sibo Zhao, Jack Shu, Patricia Baxter, Christopher L. Morton, Dias Kurmashev, Siyuan Zheng, Yidong Chen, Jay Bowen, Anthony C. Bryan, Kristen Leraas, Sara E. Coppens, HarshaVardhan Doddapaneni, Zeineen Momin, Wendong Zhang, Gregory I. Sacks, Lori S. Hart, Kateryna Krytska, Yaël P. Mossé, Gregory J. Gatto, Yolanda Sánchez, Casey S. Greene, Sharon J. Diskin, Olena M. Vaske, David Haussler, Julie M. Gastier‐Foster, E. Anders Kolb, Richard Görlick, Xiao-Nan Li, C. Patrick Reynolds, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock, Pichai Raman, David A. Wheeler, John M. Maris - Cell Reports 2019 cited by 173

  14. Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

    Authors: Steven G. DuBois, Mark Krailo, Julia Glade Bender, Allen Buxton, Nadia N. Laack, R. Lor Randall, Helen X. Chen, Nita L. Seibel, Matthew Boron, Stephanie Terezakis, Christine E. Hill‐Kayser, Andrea Hayes, Joel M. Reid, Lisa A. Teot, Dinesh Rakheja, Richard B. Womer, Carola Arndt, Stephen L. Lessnick, Brian D. Crompton, E. Anders Kolb, Heike E. Daldrup‐Link, Eric P. Eutsler, Damon R. Reed, Katherine A. Janeway, Richard Görlick - Journal of Clinical Oncology 2023 cited by 87

  15. Chemotherapy resistance in osteosarcoma: current challenges and future directions

    Authors: Alexander J. Chou, Richard Görlick - Expert Review of Anticancer Therapy 2006 cited by 381

  16. Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

    Authors: David Ebb, Paul A. Meyers, Holcombe E. Grier, Mark L. Bernstein, Richard Görlick, Steven E. Lipshultz, Mark Krailo, Meenakshi Devidas, Donald A. Barkauskas, Gene P. Siegal, William S. Ferguson, G. Douglas Letson, Karen J. Marcus, Allen M. Goorin, Peter Beardsley, Neyssa Marina - Journal of Clinical Oncology 2012 cited by 250

  17. Children's Oncology Group's 2013 blueprint for research: Bone tumors

    Authors: Richard Görlick, Katherine A. Janeway, Stephen L. Lessnick, R. Lor Randall, Neyssa Marina - Pediatric Blood & Cancer 2012 cited by 234

  18. Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

    Authors: Lisa M. Kopp, Suman Malempati, Mark Krailo, Yun Gao, Allen Buxton, Brenda J. Weigel, Thomas Hawthorne, Elizabeth Crowley, Jeffrey A. Moscow, Joel M. Reid, Víctor M. Villalobos, R. Lor Randall, Richard Görlick, Katherine A. Janeway - European Journal of Cancer 2019 cited by 78

  19. High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008

    Authors: Uta Dirksen, Bernadette Brennan, Marie‐Cécile Le Deley, Nathalie Cozic, Henk van den Berg, Vivek A. Bhadri, Bénédicte Brichard, L. Claude, Alan Craft, Susanne Amler, Natalie Gaspar, Hans Gelderblom, Robert E. Goldsby, Richard Görlick, Holcombe E. Grier, Jean-Marc Guinbretiere, Péter Hauser, Lars Hjorth, Katherine A. Janeway, Heribert Juergens, Ian Judson, Mark Krailo, Jarmila Kruseová, Thomas Kuehne, Ruth Ladenstein, Cyril Lervat, Stephen L. Lessnick, Ian Lewis, Claude Linassier, Perrine Marec‐Bérard, Neyssa Marina, Bruce Morland, Hélène Pacquement, Michael Paulussen, R. Lor Randall, Andreas Ranft, Gwénaël Le Teuff, Keith Wheatley, Jeremy Whelan, Richard B. Womer, Odile Oberlin, Douglas S. Hawkins, on behalf of the Euro-E.W.I.N.G. 99 and Ewing 2008 Investigators - Journal of Clinical Oncology 2019 cited by 145

  20. Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

    Authors: Jiemiao Hu, Qing Yang, Wendong Zhang, Hongwei Du, Yu‐Hui Chen, Qingnan Zhao, Long Dao, Xueqing Xia, Fowlkes Natalie Wall, Zhongting Zhang, Kris M. Mahadeo, Richard Görlick, Scott Kopetz, Gianpietro Dotti, Shulin Li - Journal for ImmunoTherapy of Cancer 2022 cited by 52

  21. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

    Authors: Jeremy Whelan, Stefan Bielack, Neyssa Marina, Sigbjørn Smeland, Gordana Jovic, Jane Hook, Mark Krailo, Jakob Anninga, Trude Butterfaß‐Bahloul, Tom Böhling, Gabriele Calaminus, Michael Capra, Claudia Deffenbaugh, Catharina Dhooge, Mikael Eriksson, Adrienne M. Flanagan, Hans Gelderblom, Allen M. Goorin, Richard Görlick, Georg Gosheger, R. J. Grimer, Kirsten Sundby Hall, K. Helmke, Pancras C.W. Hogendoorn, Gernot Jundt, Leo Kager, Thomas Kuehne, Ching C. Lau, G. Douglas Letson, James S. Meyer, Paul A. Meyers, Carol D. Morris, Hubert Mottl, Helen Nadel, Rajaram Nagarajan, R. Lor Randall, Paula J. Schomberg, R. Schwarz, Lisa A. Teot, Matthew R. Sydes, Mark L. Bernstein, James D. Pickering, Nicola Joffe, Matthias Kevric, Benjamin Sorg, Doojduen Villaluna, Caroline Wang, Martha Perisoglou, Leonardo Trani, Jenny Potratz, D. Carrle, Miriam Wilhelm, Katja Zils, C. Teske - Annals of Oncology 2014 cited by 333

  22. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models

    Authors: Jiemiao Hu, Alexander J. Lazar, Davis R. Ingram, Wei‐Lien Wang, Wendong Zhang, Zhiliang Jia, Dristhi Ragoonanan, Jian Wang, Xueqing Xia, Kris M. Mahadeo, Richard Görlick, Shulin Li - Journal for ImmunoTherapy of Cancer 2024 cited by 36

  23. Future directions in the treatment of osteosarcoma

    Authors: Michael W. Bishop, Katherine A. Janeway, Richard Görlick - Current Opinion in Pediatrics 2015 cited by 273

  24. Ganglioside GD2 as a therapeutic target for antibody‐mediated therapy in patients with osteosarcoma

    Authors: Michael Roth, Marissa Linkowski, John Tarim, Sajida Piperdi, Rebecca Sowers, David S. Geller, Jonathan Gill, Richard Görlick - Cancer 2013 cited by 158